The Rho GTPase signalling pathway in urothelial carcinoma
- 14 November 2017
- journal article
- review article
- Published by Springer Nature in Nature Reviews Urology
- Vol. 15 (2) , 83-91
Abstract
Urothelial carcinoma remains a clinical challenge: non-muscle-invasive disease has a high rate of recurrence and risk of progression, and outcomes for patients with advanced disease are poor, owing to a lack of effective systemic therapies. The Rho GTPase family of enzymes was first identified >30 years ago and contains >20 members, which are divided into eight subfamilies: Cdc42, Rac, Rho, RhoUV, RhoBTB, RhoDF, RhoH, and Rnd. Rho GTPases are molecular on–off switches, which are increasingly being understood to have a critical role in a number of cellular processes, including cell migration, cell polarity, cell adhesion, cell cycle progression, and regulation of the cytoskeleton. This switch is an evolutionarily conserved system in which GTPases alternate between GDP-bound (inactive) and GTP-bound (active) forms. The activities of these Rho GTPases are many, context-dependent, and regulated by a number of proteins that are being progressively elucidated. Aberrations of the Rho GTPase signalling pathways have been implicated in various malignancies, including urothelial carcinoma, and understanding of the role of Rho GTPases in these diseases is increasing. This signalling pathway has the potential for therapeutic targeting in urothelial carcinoma. Research in this area is nascent, and much work is necessary before current laboratory-based research can be translated into the clinic.Keywords
This publication has 124 references indexed in Scilit:
- Regulation of Small GTPases by GEFs, GAPs, and GDIsPhysiological Reviews, 2013
- mTORC1 and mTORC2 Regulate EMT, Motility, and Metastasis of Colorectal Cancer via RhoA and Rac1 Signaling PathwaysCancer Research, 2011
- A 20-gene model for molecular nodal staging of bladder cancer: development and prospective assessmentThe Lancet Oncology, 2011
- Regulation of Rho GTPase crosstalk, degradation and activity by RhoGDI1Nature Cell Biology, 2010
- The PHCCEx domain of Tiam1/2 is a novel protein‐ and membrane‐binding moduleThe EMBO Journal, 2009
- New Insights into How the Rho Guanine Nucleotide Dissociation Inhibitor Regulates the Interaction of Cdc42 with MembranesJournal of Biological Chemistry, 2009
- Economic aspects of bladder cancer: what are the benefits and costs?World Journal of Urology, 2009
- Evolution of the Rho Family of Ras-Like GTPases in EukaryotesMolecular Biology and Evolution, 2006
- Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitiveNature Cell Biology, 2004
- The Guanine Nucleotide-Binding Switch in Three DimensionsScience, 2001